| CYP2D7 |
A0A087X1C5
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)
|
|
|
0.659 |
0.577 |
| HLA-DRB2 |
|
major histocompatibility complex, class II, DR beta 2 (pseudogene)
|
|
|
0.861 |
0.269 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| HLA-DRB6 |
|
major histocompatibility complex, class II, DR beta 6 (pseudogene)
|
|
|
0.821 |
0.308 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| H2AC10P |
|
H2A clustered histone 10, pseudogene
|
|
|
1.000 |
0.038 |
| CMAHP |
Q9Y471
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
|
0.805 |
0.346 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| GUSBP2 |
|
GUSB pseudogene 2
|
|
|
1.000 |
0.038 |
| MIR137HG |
|
MIR137 host gene
|
|
|
0.839 |
0.038 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| MTCO3P1 |
|
MT-CO3 pseudogene 1
|
|
|
0.861 |
0.231 |
| ZSCAN16-AS1 |
|
ZSCAN16 antisense RNA 1
|
|
|
0.792 |
0.269 |
| ACTG1P22 |
|
actin gamma 1 pseudogene 22
|
|
|
0.931 |
0.038 |
| LINC00240 |
|
long intergenic non-protein coding RNA 240
|
|
|
0.821 |
0.231 |
| LINC02551 |
|
long intergenic non-protein coding RNA 2551
|
|
|
1.000 |
0.038 |
| BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| LINC01470 |
|
long intergenic non-protein coding RNA 1470
|
|
|
0.890 |
0.077 |
| EP300-AS1 |
|
EP300 antisense RNA 1
|
|
|
0.839 |
0.231 |
| SMIM15-AS1 |
|
SMIM15 antisense RNA 1
|
|
|
1.000 |
0.038 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| MEF2C-AS1 |
|
MEF2C antisense RNA 1
|
|
|
0.861 |
0.154 |
| C2-AS1 |
|
C2 antisense RNA 1
|
|
|
0.821 |
0.192 |
| RERE-AS1 |
|
RERE antisense RNA 1
|
|
|
0.890 |
0.077 |